Hydroxychloroquine WILL Save US

From NYPost.com 5/20/20

"“Cuomo mocked the president for this”[hydroxychloroquine] but “it turns out that Chris Cuomo took a less safe version of it called quinine, which the FDA removed from the market in 2006 because it had serious side effects, including death. So really interesting to have that criticism of the president.”

If you would like the "drug regimen" that Cuomo was on, please read the article in the Purist, written by his wife, Christina Cuomo.

www.thelancet.com/journals/lancet/articl...(20)31180-6/fulltext

EXTENSIVE study on use of the drug....does NOT manifest the miracle the king is making claim to.

It might be too long for this format use?

I read this study earlier and have some comments.
1. This is a retrospective case analysis, gleaned from the medical records after the fact. 2. There is discussion as to the actual drug regimen of each patient. 3. There was no determination as to whether Zinc was also given to the patients. 4. As Dr Brix stated, today, the important thing to take away from this article is the linkage of co-morbidity and the virus
5. I found it interesting that the study included patients "We included all patients hospitalised between Dec 20, 2019, and April 14, 2020, at hospitals participating in the registry and with PCR-confirmed COVID-19 infection, for whom a clinical outcome of either hospital discharge or death during hospitalisation was recorded." The inference is that HCQ and AZ was given in December of 2019.

Some important facts about Covid-19:

ramage wrote: I read this study earlier and have some comments.
1. This is a retrospective case analysis, gleaned from the medical records after the fact. 2. There is discussion as to the actual drug regimen of each patient. 3. There was no determination as to whether Zinc was also given to the patients. 4. As Dr Brix stated, today, the important thing to take away from this article is the linkage of co-morbidity and the virus
5. I found it interesting that the study included patients "We included all patients hospitalised between Dec 20, 2019, and April 14, 2020, at hospitals participating in the registry and with PCR-confirmed COVID-19 infection, for whom a clinical outcome of either hospital discharge or death during hospitalisation was recorded." The inference is that HCQ and AZ was given in December of 2019.

Retrospective case analysis...isn't EVERYTHING in retrospect when collecting RECENT case DATED
May 20 ish and collection ending at the last of APRIL.....seems current to me.

AGAIN, we are newbies when trying to understand this current condition....52 card P.U....

From your Lancet citation:
"We did a multinational registry analysis of the use of hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19. "

A registry analysis is one in which the records are looked at after the fact, i.e. treatment has been given. That is what retrospective means, not that some of the records were from, last week, last month, or last year.
The defining element in this particular analysis is that of comparing outcomes after the therapy has been ended. There is no control over what, how much or when the drugs were given.

I hope that this clears up any confusion.

ramage wrote: From your Lancet citation:
"We did a multinational registry analysis of the use of hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19. "

A registry analysis is one in which the records are looked at after the fact, i.e. treatment has been given. That is what retrospective means, not that some of the records were from, last week, last month, or last year.
The defining element in this particular analysis is that of comparing outcomes after the therapy has been ended. There is no control over what, how much or when the drugs were given.

I hope that this clears up any confusion.

bolded...after the fact....I understood that meaning. What was unclear to me was the methodology(
NOT a doc here).....was a z pak given( perhaps the medical term was included,however i was unable
to follow ALL med.terms.....) the med/research field has already confused the antibody testing numbers
tabulated (not correctly calculated....because of inclusive data that should NOT have been within the count)

SO.....THAT piece of info is inaccurate.....from reading the Lancet article...my takeaway was the trail/sampling had minimal effect/and in fact COULD be detrimental if underlying issues were present.

I am sorry but it would be helpful if you would comment in complete sentences.

What does "was a z pak given( perhaps the medical term was included,however i was unable
to follow ALL med.terms.....) the med/research field has already confused the antibody testing numbers
tabulated (not correctly calculated....because of inclusive data that should NOT have been within the count)"

I really want to answer your questions but I have to understand what you are asking.

I ask this in your previous comment the following was stated and I interpreted "
Retrospective case analysis...isn't EVERYTHING in retrospect when collecting RECENT case DATED
May 20 ish and collection ending at the last of APRIL.....seems current to me."

as meaning that you desired to know what a registry analysis (retrospective) meant. The .... seems current to me, comment led me to make that assumption.

Sorry

www.cebm.net/covid-19/what-is-the-eviden...reatmetnof-covid-19/

I was referring to Azithromycin (z-pak,because it comes in bubble pack)....NOW I know MACROLIDE is
the same.....(NOT a doctor here).....plowing thru med literature is mind-melting.